Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition
Frederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz, et al.
Psychopharmacology (2018) Vol. 235, Iss. 10, pp. 2915-2927
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Emotions and brain function are altered up to one month after a single high dose of psilocybin
Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 284
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 161
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, et al.
NeuroImage (2020) Vol. 218, pp. 116980-116980
Open Access | Times Cited: 147
Models of psychedelic drug action: modulation of cortical-subcortical circuits
Manoj K. Doss, Maxwell B. Madden, Andrew Gaddis, et al.
Brain (2021) Vol. 145, Iss. 2, pp. 441-456
Open Access | Times Cited: 143
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 110
Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape
S. Parker Singleton, Andrea I. Luppi, Robin Carhart‐Harris, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94
Spontaneous and deliberate creative cognition during and after psilocybin exposure
Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 97
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
Kristin Heuschkel, Kim P. C. Kuypers
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 74
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
Albert Garcia‐Romeu, Frederick S. Barrett, Theresa M. Carbonaro, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 353-361
Open Access | Times Cited: 72
The acute effects of classic psychedelics on memory in humans
C. J. Healy
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 639-653
Closed Access | Times Cited: 71
The role of serotonin in declarative memory: A systematic review of animal and human research
Rebecca C. Coray, Boris B. Quednow
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104729-104729
Open Access | Times Cited: 54
The costs and benefits of psychedelics on cognition and mood
Ceyda Sayalı, Frederick S. Barrett
Neuron (2023) Vol. 111, Iss. 5, pp. 614-630
Open Access | Times Cited: 24
Clinically relevant acute subjective effects of psychedelics beyond mystical experience
David B. Yaden, Sean P. Goldy, Brandon Weiss, et al.
Nature Reviews Psychology (2024) Vol. 3, Iss. 9, pp. 606-621
Closed Access | Times Cited: 12
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 1
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 50
Hazy memories in the courtroom: A review of alcohol and other drug effects on false memory and suggestibility
Lilian Kloft, Lauren A. Monds, Arjan Blokland, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 124, pp. 291-307
Open Access | Times Cited: 42
Psychedelic drugs and perception: a narrative review of the first era of research
Jacob S. Aday, Julia R. Wood, Emily K. Bloesch, et al.
Reviews in the Neurosciences (2021) Vol. 32, Iss. 5, pp. 559-571
Closed Access | Times Cited: 41
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility
Isabel Wießner, Rodolfo Olivieri, Marcelo Falchi, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 7-19
Closed Access | Times Cited: 32
Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
Jonathan W. Kanen, Qiang Luo, Mojtaba Rostami Kandroodi, et al.
Psychological Medicine (2022) Vol. 53, Iss. 14, pp. 6434-6445
Open Access | Times Cited: 32
Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition
Pablo Mallaroni, Natasha L. Mason, Johannes T. Reckweg, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 423-433
Open Access | Times Cited: 17
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2293-2304
Open Access | Times Cited: 44
Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials
Jeremy Roscoe, Olivia Lozy
Drug Science Policy and Law (2022) Vol. 8
Closed Access | Times Cited: 24
Psilocybin’s effects on cognition and creativity: A scoping review
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 635-648
Open Access | Times Cited: 15
Use of Psychedelics for Pain: A Scoping Review
Akash Goel, Yeshith Rai, Shayan Sivadas, et al.
Anesthesiology (2023) Vol. 139, Iss. 4, pp. 523-536
Closed Access | Times Cited: 14
Impact of psilocybin on cognitive function: A systematic review
Shakila Meshkat, Triana Juliana Tello‐Gerez, Fatemeh Gholaminezhad, et al.
Psychiatry and Clinical Neurosciences (2024) Vol. 78, Iss. 12, pp. 744-764
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top